Literature DB >> 3623553

Placental-like alkaline phosphatase reactivity in human tumors: an immunohistochemical study of 520 cases.

M R Wick, P E Swanson, J C Manivel.   

Abstract

Placental-like alkaline phosphatase (PLAP) activity has been reported in various human neoplasms of both somatic and germ cell types. The expression of PLAP was examined with a polyclonal antibody and the immunoperoxidase technique in formalin-fixed, paraffin-embedded sections of 37 germ cell neoplasms and 483 somatic tumors. The expression of keratin and epithelial membrane antigen (EMA) was concurrently assessed to determine whether these stains were helpful in distinguishing germ cell neoplasms from somatic tumors that might mimic them microscopically. All germ cell lesions were reactive for PLAP, but so were 62 somatic carcinomas, usually in female müllerian, intestinal, and lung cancers and less often in carcinomas of the breast and kidney. PLAP-reactive somatic tumors exhibited EMA and keratin positivity in the absence of prior protease digestion, whereas germ cell neoplasms failed to do so. Malignant mesotheliomas were nonreactive for PLAP, as were carcinomas of the nasopharynx, adrenals, liver, pancreas, stomach, prostate, and urinary bladder. PLAP is a highly sensitive but nonspecific immunohistologic marker of germ cell differentiation. However, non-protease-enhanced stains for keratin and EMA allow separation of germ cell and somatic carcinomas, despite their shared capacity for PLAP expression. In somatic neoplasms, PLAP immunoreactivity might be of potential use in predicting possible primary sources for metastatic tumors of unknown origin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3623553     DOI: 10.1016/s0046-8177(87)80274-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

1.  Metastatic seminomas in lymph nodes: CD10 immunoreactivity can be a pitfall of differential diagnosis.

Authors:  Yasunori Ota; Kuniko Iihara; Tomiko Ryu; Teppei Morikawa; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

2.  Germ cell tumour as a diagnostic pitfall of metastatic carcinoma.

Authors:  T W Shek; S T Yuen; I S Luk; M P Wong
Journal:  J Clin Pathol       Date:  1996-03       Impact factor: 3.411

Review 3.  Morphological approach to tumours of the testis and paratestis.

Authors:  Robert E Emerson; Thomas M Ulbright
Journal:  J Clin Pathol       Date:  2007-02-16       Impact factor: 3.411

Review 4.  Placental-like alkaline phosphatase in seminoma.

Authors:  K Koshida; B Wahren
Journal:  Urol Res       Date:  1990

5.  ALPPL2 Is a Highly Specific and Targetable Tumor Cell Surface Antigen.

Authors:  Yang Su; Xin Zhang; Scott Bidlingmaier; Christopher R Behrens; Nam-Kyung Lee; Bin Liu
Journal:  Cancer Res       Date:  2020-08-31       Impact factor: 12.701

Review 6.  American Registry of Pathology Expert Opinions: Evaluation of poorly differentiated malignant neoplasms on limited samples - Gastrointestinal mucosal biopsies.

Authors:  Andrew M Bellizzi; Elizabeth A Montgomery; Jason L Hornick
Journal:  Ann Diagn Pathol       Date:  2019-11-15       Impact factor: 2.090

7.  Placental alkaline phosphatase in developing normal and abnormal gonads and in germ-cell tumours.

Authors:  J Hustin; Y Gillerot; J Collette; P Franchimont
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

8.  A combined approach to data mining of textual and structured data to identify cancer-related targets.

Authors:  Pavel Pospisil; Lakshmanan K Iyer; S James Adelstein; Amin I Kassis
Journal:  BMC Bioinformatics       Date:  2006-07-20       Impact factor: 3.169

9.  Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma.

Authors:  Kristine R Jakobsen; Birgitte S Paulsen; Rikke Bæk; Kim Varming; Boe S Sorensen; Malene M Jørgensen
Journal:  J Extracell Vesicles       Date:  2015-03-02

Review 10.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.